Klaus Annewanter Email

Therapy Development Manager DACH . Phagenesis Ltd

Current Roles

Employees:
32
Revenue:
$8M
About
We have developed the world first clinically proven treatment for dysphagia following neurological conditions. The treatment, Phagenyx, is the result of more than 20 years development by Professor Shaheen Hamdy and his team at the University of Manchester. Phagenyx is available in the Germany, Austria, the UK, Ireland and other european countries. For further information See our website www.phagenesis.com Like our Facebook page https://www.facebook.com/phagenesis Follow us on Twitter https://twitter.com/Phagenesis
Phagenesis Ltd Address
Manchester Science Park
Manchester, null
Phagenesis Ltd Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.